December 5, 2025

AnaptysBio, Inc. (ANAB) Stock Analysis: A Biotech Play With 47.60% Potential Upside

AnaptysBio, Inc. (NASDAQ: ANAB) stands out in the biotechnology sector with its innovative focus on immunology therapeutics. Based in San Diego, the company has carved a niche by developing cutting-edge..

Oculis Holding AG (OCS) Stock Analysis: A Potential 125.95% Upside in Biotech Innovation

Oculis Holding AG (NASDAQ: OCS), a promising player in the healthcare sector, is garnering attention from investors with its significant growth potential. Specializing in biotechnology, the Swiss-based company is making..

Vir Biotechnology, Inc. (VIR) Stock Analysis: A Strategic Look at 154% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a promising portfolio aimed at combating serious infectious diseases. Headquartered in San Francisco,..

Claritev Corporation (CTEV) Stock Analysis: A Potential 130% Upside in the Healthcare Sector

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare sector, is capturing investor attention with its innovative approach to data analytics and cost management solutions. Based in New York..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a Potential 18.96% Upside in Healthcare Diagnostics

Fulgent Genetics, Inc. (NASDAQ: FLGT) operates in the dynamic Healthcare sector, specifically within the Diagnostics & Research industry. Headquartered in El Monte, California, this U.S.-based company has carved a niche..

Mind Medicine (MNMD) Stock Analysis: Exploring a 106% Potential Upside in the Biotech Space

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a promising player in the biotechnology sector, is making waves with its innovative approach to treating brain health disorders. Headquartered in New York, the..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A 160% Potential Upside Sparks Investor Interest

Zevra Therapeutics, Inc. (ZVRA), a promising player in the biotechnology industry, has been capturing the attention of investors with its remarkable potential upside. The company, headquartered in Celebration, Florida, and..

Bicycle Therapeutics plc (BCYC) Stock Report: A 191.57% Potential Upside in the Biotech Arena

Bicycle Therapeutics plc (NASDAQ: BCYC), a burgeoning entity in the biotechnology sector, is drawing significant attention from investors with its impressive potential upside of 191.57%. This clinical-stage pharmaceutical company, headquartered..

Owens & Minor, Inc. (OMI) Stock Analysis: A Look at Its 123.53% Potential Upside

Owens & Minor, Inc. (NYSE: OMI), a key player in the healthcare sector, offers intriguing prospects for investors despite current challenges. Trading at a modest $2.55 per share, OMI has..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 147.99% Potential Upside for Investors

LifeMD, Inc. (NASDAQ: LFMD), a prominent player in the healthcare sector, offers an intriguing proposition for investors seeking opportunities in the burgeoning telehealth industry. With a market capitalization of $179.55..

REGENXBIO Inc. (RGNX) Stock Analysis: Eyeing a 127.62% Upside with Robust Buy Ratings

Investors looking at the biotechnology sector should keep a close eye on REGENXBIO Inc. (RGNX), a clinical-stage biotech firm specializing in gene therapies. With its headquarters in Rockville, Maryland, REGENXBIO..

Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Exploring a 132.59% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a prominent player in the biotechnology sector, has been the subject of considerable attention from investors, primarily due to its promising pipeline of gene therapies..

Iovance Biotherapeutics (IOVA) Stock Analysis: Unveiling a 275% Potential Upside in the Biotech Sector

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a key player in the biotechnology sector, has attracted considerable attention from investors with its promising portfolio of therapies aimed at combatting metastatic melanoma and..

Zenas BioPharma (ZBIO) Stock Analysis: Exploring an 18% Upside Potential with Strong Buy Ratings

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its promising pipeline and significant upside potential. As a player in the burgeoning..

Delcath Systems, Inc. (DCTH) Stock Analysis: Poised for a 122% Upside in the Medical Device Sector

Delcath Systems, Inc. (NASDAQ: DCTH) is capturing investor attention with a remarkable potential upside of 122.60%, driven by its innovative approach to treating liver cancers. This New York-based healthcare company..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Navigating a 32.87% Potential Upside in Pediatric Orthopedics

OrthoPediatrics Corp. (NASDAQ: KIDS), a trailblazer in the pediatric medical device industry, presents a compelling opportunity for investors seeking growth in the healthcare sector. With a market capitalization of $455.66..

CareDx, Inc. (CDNA) Investor Outlook: Analyzing a 15% Potential Upside in the Healthcare Diagnostics Sector

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare diagnostics sector, has captured the interest of investors with a noteworthy potential upside of 15.06%, according to recent analyst ratings...

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a 75% Potential Upside for Biotech Innovators

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is catching the eye of investors with a notable 75.42% potential upside, driven by its promising pipeline and strategic partnerships. Headquartered..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a 78.47% Potential Upside for Savvy Investors

Eton Pharmaceuticals, Inc. (ETON), a burgeoning player in the healthcare sector, is garnering attention from investors with its impressive growth trajectory and promising financial outlook. Based in Deer Park, Illinois,..

Beta Bionics, Inc. (BBNX) Investor Outlook: A Healthcare Pioneer with Strong Revenue Growth and Analyst Confidence

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the healthcare sector, specifically within the medical devices industry. Focused on improving the lives of individuals requiring insulin, this U.S.-based company..

Search

Funds

December 5, 2025

Search

Funds

December 5, 2025

FTSE 100

Funds